Amiodarone and thyroid physiology, pathophysiology, diagnosis and management
Tóm tắt
Từ khóa
Tài liệu tham khảo
Vassallo, 2007, Prescribing amiodarone: an evidence-based review of clinical indications, JAMA, 298, 1312, 10.1001/jama.298.11.1312
Singh, 2008, Amiodarone as paradigm for developing new drugs for atrial fibrillation, J Cardiovasc Pharmacol, 52, 300, 10.1097/FJC.0b013e31818914b6
Rosenbaum, 1983, Ten years of experience with amiodarone, Am Heart J, 106, 957, 10.1016/0002-8703(83)90022-4
Rosenbaum, 1976, Clinical efficacy of amiodarone as an antiarrhythmic agent, Am J Cardiol, 38, 934, 10.1016/0002-9149(76)90807-9
Fogoros RN. The Strange History of Amiodarone. Available at https://www.verywellhealth.com/the-strange-history-of-amiodarone-1745987 Last accessed 8/9/18.
Winkle, 1985, Amiodarone and the American Way, J Am Coll Cardiol, 6, 822, 10.1016/S0735-1097(85)80489-7
Pritchett, 1998, Evolution and revolution in drug labeling: regulation of antiarrhythmic drugs by the Food and Drug Administration 1962–1996, Pacing Clin Electrophysiol, 21, 1457, 10.1111/j.1540-8159.1998.tb00218.x
Kudenchuk, 1999, Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation, N Engl J Med, 341, 871, 10.1056/NEJM199909163411203
Dorian, 2002, Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation, N Engl J Med, 346, 884, 10.1056/NEJMoa013029
Nademanee, 2000, Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy, Circulation, 102, 742, 10.1161/01.CIR.102.7.742
Ortiz, 2017, Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study, Eur Heart J, 38, 1329
Al-Khatib, 2017, J Am Coll Cardiol
Pinski, 1995, Implantable cardioverter-defibrillators: implications for the nonelectrophysiologist, Ann Intern Med, 122, 770, 10.7326/0003-4819-122-10-199505150-00007
Sweeney, 2012, There are lots of things about implantable cardioverter-defibrillators that should be eliminated: shocks are a good start, Heart Rhythm, 9, 2075, 10.1016/j.hrthm.2012.09.002
Sweeney, 2010, Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients, Heart Rhythm, 7, 353, 10.1016/j.hrthm.2009.11.027
Dev, 2014, Prevalence, correlates, and temporal trends in antiarrhythmic drug use at discharge after implantable cardioverter defibrillator placement (from the National Cardiovascular Data Registry [NCDR]), Am J Cardiol, 113, 314, 10.1016/j.amjcard.2013.09.023
Zimetbaum, 2012, Antiarrhythmic drug therapy for atrial fibrillation, Circulation, 125, 381, 10.1161/CIRCULATIONAHA.111.019927
Aasbo, 2005, Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis, Ann Intern Med, 143, 327, 10.7326/0003-4819-143-5-200509060-00008
Kumar K, Zimetbaum PJ. Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: clinical trials. Available at: https://www.uptodate.com/contents/antiarrhythmic-drugs-to-maintain-sinus-rhythm-in-patients-with-atrial-fibrillation-clinical-trials?topicRef=1033&source=see_link Last accessed 8/9/18.
Di Biase, 2016, Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial, Circulation, 133, 1637, 10.1161/CIRCULATIONAHA.115.019406
Al-Khatib, 2003, Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000, Am J Cardiol, 91, 91, 10.1016/S0002-9149(02)03008-4
Cordarone® (amiodarone HCl) TABLETS. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018972s044lbl.pdf Last accessed 8/8/18.
Martino, 2001, The effects of amiodarone on the thyroid, Endocr Rev, 22, 240
Gopalan
Harjai, 1997, Effects of amiodarone on thyroid function, Ann Intern Med, 126, 63, 10.7326/0003-4819-126-1-199701010-00009
Albert, 1987, Thyroid dysfunction during chronic amiodarone therapy, J Am Coll Cardiol, 9, 175, 10.1016/S0735-1097(87)80098-0
Cohen-Lehman, 2010, Effects of amiodarone therapy on thyroid function, Nat Rev Endocrinol, 6, 34, 10.1038/nrendo.2009.225
Vorperian, 1997, Adverse effects of low dose amiodarone: a meta-analysis, J Am Coll Cardiol, 30, 791, 10.1016/S0735-1097(97)00220-9
Singh, 1994
Bonow, 2011
Campbell, 2001, Therapeutic drug monitoring: antiarrhythmic drugs, Br J Clin Pharmacol, 52, 21S, 10.1046/j.1365-2125.2001.00768.x
Goldschlager, 2000, Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology, Arch Intern Med, 160, 1741, 10.1001/archinte.160.12.1741
Ohyama, 2000, Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions, Br J Clin Pharmacol, 49, 244, 10.1046/j.1365-2125.2000.00134.x
Katoh, 2001, Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport, Eur J Pharm Sci, 12, 505, 10.1016/S0928-0987(00)00215-3
Ross DS. Amiodarone and thyroid dysfunction. Available at: https://www.uptodate.com/contents/amiodarone-and-thyroid-dysfunction Last accessed 8/8/18.
Koenig, 2005, Regulation of type 1 iodothyronine deiodinase in health and disease, Thyroid, 15, 835, 10.1089/thy.2005.15.835
Sagar, 2008, The thyroid hormone-inactivating deiodinase functions as a homodimer, Mol Endocrinol, 22, 1382, 10.1210/me.2007-0490
Bianco, 2002, Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases, Endocr Rev, 23, 38, 10.1210/edrv.23.1.0455
Gereben, 2008, Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling, Endocr Rev, 29, 898, 10.1210/er.2008-0019
Aanderud, 1984, Amiodarone inhibits the conversion of thyroxine to triiodothyronine in isolated rat hepatocytes, Endocrinology, 115, 1605, 10.1210/endo-115-4-1605
Hershman, 1986, Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone, Acta Endocrinol (Copenh), 111, 193, 10.1530/acta.0.1110193
Gotzsche, 1989, Rat heart thyroxine 5′-deiodinase is sensitively depressed by amiodarone, J Cardiovasc Pharmacol, 14, 836, 10.1097/00005344-198912000-00006
Ceppi, 1988, Effect of amiodarone on the conversion of thyroxine to triiodothyronine in the myocardium of rats in vivo and in vitro, Medicina (B Aires), 48, 29
Balsam, 1978, The influence of fasting, diabetes, and several pharmacological agents on the pathways of thyroxine metabolism in rat liver, J Clin Invest, 62, 415, 10.1172/JCI109143
Sogol, 1983, The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5′-monodeiodination in rats, Endocrinology, 113, 1464, 10.1210/endo-113-4-1464
Pekary, 1986, Amiodarone inhibits T4 to T3 conversion and alpha-glycerophosphate dehydrogenase and malic enzyme levels in rat liver, Horm Metab Res, 18, 114, 10.1055/s-2007-1012245
Ceppi, 1989, Effects of amiodarone on 5′-deiodination of thyroxine to tri- iodothyronine in rat myocardium, J Endocrinol, 121, 431, 10.1677/joe.0.1210431
Ha, 2000, Structure-effect relationships of amiodarone analogues on the inhibition of thyroxine deiodination, Eur J Clin Pharmacol, 55, 807, 10.1007/s002280050701
Hudig, 1994, Amiodarone-induced hypercholesterolemia is associated with a decrease in liver LDL receptor mRNA, FEBS Lett, 341, 86, 10.1016/0014-5793(94)80245-9
Kaplan, 1988, Human epidermal keratinocytes in culture convert thyroxine to 3,5,3′-triiodothyronine by type II iodothyronine deiodination: a novel endocrine function of the skin, J Clin Endocrinol Metab, 66, 815, 10.1210/jcem-66-4-815
Kaplan, 1984, Conversion of thyroxine to triiodothyronine in the anterior pituitary gland and the influence of this process on thyroid status, Horm Metab Res Suppl, 14, 79
Christoffolete, 2006, Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin feedback mechanism, Endocrinology, 147, 1735, 10.1210/en.2005-1300
Fekete, 2007, Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase, Front Neuroendocrinol, 28, 97, 10.1016/j.yfrne.2007.04.002
Abdalla, 2014, Defending plasma T3 is a biological priority, Clin Endocrinol, 81, 633, 10.1111/cen.12538
Burger, 1976, Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones, J Clin Invest, 58, 255, 10.1172/JCI108466
Melmed, 1981, Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration, J Clin Endocrinol Metab, 53, 997, 10.1210/jcem-53-5-997
Nademanee, 1982, Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy, Circulation, 66, 202, 10.1161/01.CIR.66.1.202
Schneider, 2001, Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4, Mol Endocrinol, 15, 2137, 10.1210/mend.15.12.0740
Shi, 2008, Long-term amiodarone treatment causes cardioselective hypothyroid-like alteration in gene expression profile, Eur J Pharmacol, 578, 270, 10.1016/j.ejphar.2007.09.039
Krenning, 1982, Decreased transport of thyroxine (T4), 3,3′,5-triiodothyronine (T3) and 3,3′,5′-triiodothyronine (rT3) into rat hepatocytes in primary culture due to a decrease of cellular ATP content and various drugs, FEBS Lett, 140, 229, 10.1016/0014-5793(82)80900-9
Bakker, 1994, Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone beta 1-receptor protein, Endocrinology, 134, 1665, 10.1210/endo.134.4.8137729
van Beeren, 1995, Desethylamiodarone is a competitive inhibitor of the binding of thyroid hormone to the thyroid hormone alpha 1-receptor protein, Mol Cell Endocrinol, 112, 15, 10.1016/0303-7207(95)03578-U
Bogazzi, 2001, Desethylamiodarone antagonizes the effect of thyroid hormone at the molecular level, Eur J Endocrinol, 145, 59, 10.1530/eje.0.1450059
Pachucki, 2001, Type 2 iodothyronine deiodinase transgene expression in the mouse heart causes cardiac-specific thyrotoxicosis, Endocrinology, 142, 13, 10.1210/endo.142.1.7907
Carvalho-Bianco, 2004, Chronic cardiac-specific thyrotoxicosis increases myocardial beta-adrenergic responsiveness, Mol Endocrinol, 18, 1840, 10.1210/me.2003-0125
Trivieri, 2006, Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction, PNAS, 103, 6043, 10.1073/pnas.0601072103
Peeters, 2003, Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients, J Clin Endocrinol Metab, 88, 3202, 10.1210/jc.2002-022013
Ueta, 2012, Absence of myocardial thyroid hormone inactivating deiodinase results in restrictive cardiomyopathy in mice, Mol Endocrinol, 26, 809, 10.1210/me.2011-1325
Olivares, 2007, Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study, Endocrinology, 148, 4786, 10.1210/en.2007-0043
Wassen, 2002, Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure, Endocrinology, 143, 2812, 10.1210/endo.143.7.8985
Simonides, 2008, Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats, J Clin Invest, 118, 975
Hong, 2013, Cardiac expression of human type 2 iodothyronine deiodinase increases glucose metabolism and protects against doxorubicin-induced cardiac dysfunction in male mice, Endocrinology, 10.1210/en.2012-2261
Tracy CM. Tachycardia-mediated cardiomyopathy. 8/7/2015 cited; Available from: http://www.uptodate.com/contents/tachycardia-mediated-cardiomyopathy.
Singh, 1995, Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure, New Engl J Med, 333, 77, 10.1056/NEJM199507133330201
Beddows, 1989, Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes, Biochem Pharmacol, 38, 4397, 10.1016/0006-2952(89)90648-5
Pitsiavas, 1997, Amiodarone induces a different pattern of ultrastructural change in the thyroid to iodine excess alone in both the BB/W rat and the Wistar rat, Eur J Endocrinol, 137, 89, 10.1530/eje.0.1370089
Wiersinga, 1997, Towards an animal model of amiodarone-induced thyroid dysfunction, Eur J Endocrinol, 137, 15, 10.1530/eje.0.1370015
Lombardi, 2015, Endoplasmic reticulum stress as a novel mechanism in amiodarone-induced destructive thyroiditis, J Clin Endocrinol Metab, 100, E1, 10.1210/jc.2014-2745
Rani, 1990, Amiodarone effects on thyrotropin receptors and responses stimulated by thyrotropin and carbachol in cultured dog thyroid cells, Endocrinology, 127, 2930, 10.1210/endo-127-6-2930
Amico, 1984, Clinical and chemical assessment of thyroid function during therapy with amiodarone, Arch Intern Med, 144, 487, 10.1001/archinte.1984.00350150071023
Trip, 1991, Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism, Am J Med, 91, 507, 10.1016/0002-9343(91)90187-3
Foresti, 1985, Amiodarone and antithyroid antibodies, Ann Intern Med, 103, 157, 10.7326/0003-4819-103-1-157_2
Selenkow, 1965, An autoregulatory effect of iodide in diverse thyroid disorders, Ann Intern Med, 62, 714, 10.7326/0003-4819-62-4-714
Martino, 1984, Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy, Ann Intern Med, 101, 28, 10.7326/0003-4819-101-1-28
Narayana, 2011, Management of amiodarone-related thyroid problems, Ther Adv Endocrinol Metab, 2, 115, 10.1177/2042018811398516
Amouzegar, 2017, The prevalence, incidence and natural course of positive antithyroperoxidase antibodies in a population-based study: Tehran thyroid study, PLoS One, 12
Ai, 2003, Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic manifestations, J Am Acad Dermatol, 48, 641, 10.1067/mjd.2003.257
Nademanee, 1989, Amiodarone and thyroid function, Progr Cardiovasc Dis, 31, 427, 10.1016/0033-0620(89)90017-0
Ursella, 2005, Amiodarone-induced thyroid dysfunction in clinical practice, Eur Rev Med Pharmacol Sci, 10, 269
Jackson, 1978, Why does anyone still use desiccated thyroid USP?, Am J Med, 64, 284, 10.1016/0002-9343(78)90057-8
Lazarus, 2009, Lithium and thyroid, Best Pract Res Clin Endocrinol Metab, 23, 723, 10.1016/j.beem.2009.06.002
Surks MI. Lithium and the thyroid. Available at: https://www.uptodate.com/contents/lithium-and-the-thyroid Last accessed 8/13/18.
Chakraborty, 2014, Amiodarone-induced myxedema coma - a case and review of the literature, Arch Med Sci, 10, 1263, 10.5114/aoms.2013.35026
Hylander, 1985, Treatment of myxoedema coma–factors associated with fatal outcome, Acta Endocrinol, 108, 65, 10.1530/acta.0.1080065
Dutta, 2008, Predictors of outcome in myxoedema coma: a study from a tertiary care centre, Crit Care, 12, R1, 10.1186/cc6211
Ross DS. Myxedema coma. 5/31/2015 [cited; Available from: http://www.uptodate.com/contents/myxedema-coma Last accessed 8/13/18.
Ingbar, 1972, Autoregulation of the thyroid. Response to iodide excess and depletion, Mayo Clin Proc, 47, 814
Leger, 1983, Thyroid iodine content measured by x-ray fluorescence in amiodarone-induced thyrotoxicosis: concise communication, J Nucl Med, 24, 582
Daniels, 2001, Amiodarone-induced thyrotoxicosis, J Clin Endocrinol Metab, 86, 3, 10.1210/jcem.86.1.7119
Newnham, 1988, Amiodarone-induced hyperthyroidism: assessment of the predictive value of biochemical testing and response to combined therapy using propylthiouracil and potassium perchlorate, Aust N Z J Med, 18, 37, 10.1111/j.1445-5994.1988.tb02237.x
Tsang, 2009, Amiodarone-induced thyrotoxicosis: a review, Can J Cardiol, 25, 421, 10.1016/S0828-282X(09)70512-4
Stan, 2012, A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart disease, J Thyroid Res, 2012, 10.1155/2012/210529
Stan, 2013, Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease–a cohort study, Int J Cardiol, 167, 821, 10.1016/j.ijcard.2012.02.015
Credner, 1998, Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications, J Am Coll Cardiol, 32, 1909, 10.1016/S0735-1097(98)00495-1
Tomisti, 2013, Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature, Endocr Pract, 19, 1043, 10.4158/EP13093.RA
Harjai, 1996, Amiodarone induced hyperthyroidism: a case series and brief review of literature, Pacing Clin Electrophysiol, 19, 1548, 10.1111/j.1540-8159.1996.tb03179.x
Brennan, 1987, Amiodarone-associated thyrotoxicosis (AAT): experience with surgical management, Surgery, 102, 1062
Leger, 1984, Iodine-induced thyrotoxicosis: analysis of eighty-five consecutive cases, Eur J Clin Invest, 14, 449, 10.1111/j.1365-2362.1984.tb01212.x
Singh, 1970, The effect of amiodarone, a new anti-anginal drug, on cardiac muscle, Br J Pharmacol, 39, 657, 10.1111/j.1476-5381.1970.tb09891.x
Franklyn, 1985, Amiodarone and thyroid hormone action, Clin Endocrinol (Oxf), 22, 257, 10.1111/j.1365-2265.1985.tb03238.x
Marcus, 1981, Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone, Am Heart J, 101, 480, 10.1016/0002-8703(81)90140-X
Bartalena, 1996, Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study, J Clin Endocrinol Metab, 81, 2930
Bartalena, 1994, Serum interleukin-6 in amiodarone-induced thyrotoxicosis, J Clin Endocrinol Metab, 78, 423
Godley, 1954, Preliminary experience in the treatment of hyperthyroidism with potassium perchlorate, J Clin Endocrinol Metab, 14, 70, 10.1210/jcem-14-1-70
Braverman, 2005, The effect of perchlorate, thiocyanate, and nitrate on thyroid function in workers exposed to perchlorate long-term, J Clin Endocrinol Metab, 90, 700, 10.1210/jc.2004-1821
Martino, 1986, Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole, J Endocrinol Invest, 9, 201, 10.1007/BF03348098
Trotter, 1962, The relative toxicity of antithyroid drugs, J New Drugs, 2, 333, 10.1177/009127006200200603
Wenzel, 1984, Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs, J Clin Endocrinol Metab, 58, 62, 10.1210/jcem-58-1-62
De Weweire, 1987, Failure to control hyperthyroidism with a thionamide after KClO4 withdrawal in a patient with amiodarone associated thyrotoxicosis, J Endocrinol Invest, 10, 529, 10.1007/BF03348187
Ross DS. Pharmacology and toxicity of thionamides. Available at: http://www.uptodate.com/contents/pharmacology-and-toxicity-of-thionamides. Last accessed 8/13/18.
Andersohn, 2007, Systematic review: agranulocytosis induced by nonchemotherapy drugs, Ann Intern Med, 146, 657, 10.7326/0003-4819-146-9-200705010-00009
Watanabe, 2012, Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease, J Clin Endocrinol Metab, 97, E49, 10.1210/jc.2011-2221
Dickstein, 1997, Lithium treatment in amiodarone-induced thyrotoxicosis, Am J Med, 102, 454, 10.1016/S0002-9343(97)00047-8
Bagchi, 1978, Studies on the mechanism of inhibition of thyroid function by lithium, Biochim Biophys Acta, 542, 163, 10.1016/0304-4165(78)90242-8
Burrow, 1971, Effect of lithium on thyroid function, J Clin Endocrinol Metab, 32, 647, 10.1210/jcem-32-5-647
Spaulding, 1972, The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients, J Clin Endocrinol Metab, 35, 905, 10.1210/jcem-35-6-905
Ross DS. Beta blockers in the treatment of hyperthyroidism. Available at: http://www.uptodate.com/contents/beta-blockers-in-the-treatment-of-hyperthyroidism Last accessed 8/13/18.
Nayak, 2006, Thyrotoxicosis and thyroid storm, Endocrinol Metab Clin North Am, 35, 663, 10.1016/j.ecl.2006.09.008
Chiha, 2015, Thyroid storm: an updated review, J Intensive Care Med, 30, 131, 10.1177/0885066613498053
Burch, 1993, Graves' ophthalmopathy: current concepts regarding pathogenesis and management, Endocr Rev, 14, 747
Wartofsky, 1970, Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis, J Clin Invest, 49, 78, 10.1172/JCI106225
Kaykhaei, 2008, Low doses of cholestyramine in the treatment of hyperthyroidism, Endocrine, 34, 52, 10.1007/s12020-008-9107-5
Tsai, 2005, The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism, Clin Endocrinol, 62, 521, 10.1111/j.1365-2265.2005.02249.x
Mercado, 1996, Treatment of hyperthyroidism with a combination of methimazole and cholestyramine, J Clin Endocrinol Metab, 81, 3191
Carhill, 2012, Surviving the storm: two cases of thyroid storm successfully treated with plasmapheresis, BMJ Case Rep, 2012, 10.1136/bcr-2012-006696
Maqdasy, 2016, Amiodarone-induced thyrotoxicosis recurrence after amiodarone reintroduction, Am J Cardiol, 117, 1112, 10.1016/j.amjcard.2016.01.003
Solomon, 1990, Current trends in the management of Graves' disease, J Clin Endocrinol Metab, 70, 1518, 10.1210/jcem-70-6-1518
Meurisse M, Hamoir E, D'Silva M, Joris J, Hennen G. Amiodarone-induced thyrotoxicosis: is there a place for surgery? World journal of surgery. 1993; 17(5): 622–6; discussion 7.
Mulligan, 1993, Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy, Surgery, 114, 1114
Querat, 2015, Surgical management of hyperthyroidism, Eur Ann Otorhinolaryngol, Head Neck Dis, 132, 63, 10.1016/j.anorl.2014.04.005
Scholz, 2003, Is there a place for thyroidectomy in older patients with thyrotoxic storm and cardiorespiratory failure?, Thyroid, 13, 933, 10.1089/105072503322511337
Farwell, 1990, Thyroidectomy for amiodarone-induced thyrotoxicosis, JAMA, 263, 1526, 10.1001/jama.1990.03440110092034
Joghetaei, 2011, Acute liver failure associated with dronedarone, Circ Arrhythmia Electrophysiol, 4, 592, 10.1161/CIRCEP.111.963447
Skaper, 2012, Endocannabinoids in nervous system health and disease: the big picture in a nutshell, Philos Trans R Soc Lond Ser B, 367, 3193, 10.1098/rstb.2012.0313
Hohnloser, 2009, Effect of dronedarone on cardiovascular events in atrial fibrillation, N Engl J Med, 360, 668, 10.1056/NEJMoa0803778
Hernandez Voth, 2012, A 73-year-old man with interstitial lung disease due to dronedarone, Am J Respir Crit Care Med, 186, 201, 10.1164/ajrccm.186.2.201
Le Heuzey, 2010, A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study, J Cardiovasc Electrophysiol, 21, 597, 10.1111/j.1540-8167.2010.01764.x
Exposito V, Rodriguez-Entem F, Gonzalez-Enriquez S, Olalla JJ. Dronedarone for recurrent ventricular tachycardia: a real alternative? Indian Pacing Electrophysiol J. 2012; 12(2): 73–6.
Shaaraoui, 2011, Suppression of ventricular tachycardia with dronedarone: a case report, J Cardiovasc Electrophysiol, 22, 201
Kober, 2008, Increased mortality after dronedarone therapy for severe heart failure, N Engl J Med, 358, 2678, 10.1056/NEJMoa0800456
Davy, 2008, Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study, Am Heart J, 156, 527, 10.1016/j.ahj.2008.06.010
Connolly, 2011, Dronedarone in high-risk permanent atrial fibrillation, N Engl J Med, 365, 2268, 10.1056/NEJMoa1109867
Page, 2016, 2015 ACC/AHA/ HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, Circulation, 133, e506
Giardina EG, Zimetbaum PJ. Amiodarone: monitoring and management of side effects. Available at: https://www.uptodate.com/contents/amiodarone-monitoring-and-management-of-sideeffects?search=amiodarone%20toxicity&source=search_result&selectedTitle=1∼48&usage_type=default&display_rank=1.